Agios Announces Exclusive Worldwide License Agreement for Novel siRNA for the Potential Treatment of Polycythemia Vera

MLA

“Agios Announces Exclusive Worldwide License Agreement for Novel SiRNA for the Potential Treatment of Polycythemia Vera.” GlobeNewswire, 3 Aug. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.759426008&authtype=sso&custid=ns315887.

APA

Agios Announces Exclusive Worldwide License Agreement for Novel siRNA for the Potential Treatment of Polycythemia Vera. (2023, August 3). GlobeNewswire.

Chicago

GlobeNewswire. 2023. “Agios Announces Exclusive Worldwide License Agreement for Novel SiRNA for the Potential Treatment of Polycythemia Vera,” August 3. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.759426008&authtype=sso&custid=ns315887.